Product correctly added to cart.

discount label
ONO 8130
View 3D

Biosynth logo

ONO 8130

CAS: 459841-96-4

Ref. 3D-BO178747

1mgTo inquire
5mgTo inquire
10mgTo inquire
Estimated delivery in United States, on Thursday 23 Jan 2025

Product Information

Name:
ONO 8130
Description:

ONO-8130 is a new, potent and selective agonist of the prostanoid receptor EP2. It has been shown to have a concentration-dependent antinociceptive effect in both anesthetized and non-anesthetized animals. In functional studies, ONO-8130 inhibits the spontaneous firing of neurons from the dorsal root ganglia (DRG) in a dose-dependent manner, which may be mediated by an action on EP2 receptors. ONO-8130 also inhibits the release of nociceptive neurotransmitters such as histamine from rat peritoneal mast cells. The drug has been found to have antihistaminic activity in rats but not in guinea pigs or mice. This may be due to its ability to activate EP2 receptors in the bladder muscle and/or its affinity for vascular endothelial cells that express EP2 receptors. These actions may account for its antihistaminic effects observed in rats but not mice or

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
500.63 g/mol
Formula:
C25H28N2O5S2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BO178747 ONO 8130

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".